Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $1.8 million.

  • Prokidney's Other Accumulated Expenses fell 3196.19% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 3196.19%. This contributed to the annual value of $1.9 million for FY2024, which is 2441.41% up from last year.
  • As of Q3 2025, Prokidney's Other Accumulated Expenses stood at $1.8 million, which was down 3196.19% from $1.2 million recorded in Q2 2025.
  • Prokidney's Other Accumulated Expenses' 5-year high stood at $2.6 million during Q3 2024, with a 5-year trough of $21000.0 in Q4 2022.
  • For the 4-year period, Prokidney's Other Accumulated Expenses averaged around $1.3 million, with its median value being $1.5 million (2023).
  • In the last 5 years, Prokidney's Other Accumulated Expenses skyrocketed by 721428.57% in 2023 and then crashed by 4404.82% in 2025.
  • Prokidney's Other Accumulated Expenses (Quarter) stood at $21000.0 in 2022, then skyrocketed by 7214.29% to $1.5 million in 2023, then increased by 24.41% to $1.9 million in 2024, then fell by 6.54% to $1.8 million in 2025.
  • Its Other Accumulated Expenses stands at $1.8 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.6 million for Q1 2025.